top of page

Edward Robb DVM, MS DACVM -
Chief of Regulatory & Veterinarian Affairs

Dr. Robb is an experienced leader known for building successful, innovative global teams that have registered new veterinary products with current annual sales exceeding $500 million USD. His scientific interests encompass internal medicine, infectious diseases, and production diseases of livestock, as well as the regulation of veterinary drugs, food safety, and clinical trial design/epidemiology. He has led global project teams and research organizations that delivered groundbreaking pharmaceutical and biological (vaccine) projects, creating many of the most valuable animal health brand families widely used by veterinarians, producers, and pet owners worldwide.

In 2008, Dr. Robb was appointed Vice President of Research and Development at Boehringer Ingelheim Vetmedica Inc. (BIVI) in St. Joseph, Missouri. He expanded this research and development organization in the US from 90 full-time employees to over 240 and increased annual research investment from less than $30 million to over $70 million USD. In 2013, Dr. Robb joined Ceva Animal Health as Vice President of Business Development, later serving as Vice President of Pharmaceutical Research in the US. In late 2014, he was named Chief Scientific Officer of Parnell Veterinary Pharmaceuticals, which completed an IPO in June 2014. Dr. Robb left Parnell in December 2015.

Also in 2013, Dr. Robb founded BioPharmaPotentials LLC, specializing in animal health product development. The company provides consulting services and executes regulatory and development strategies to maximize the potential of new or existing chemical or biologic entities. Engagements range from traditional consulting roles to serving as Chief Scientific and/or Veterinary Program Officer for early-phase global clients.

Following clinical practice and a lecturing position at the University of Pennsylvania, Dr. Robb moved to product development at the American Cyanamid Company in 1986, holding various technical and business/marketing roles in Animal Health. Later, at The Upjohn Company in Kalamazoo, MI, he served as Director and Senior Director of Worldwide Animal Health Clinical Research and Product Development. He continued in this role at Pharmacia and Upjohn and at Pharmacia Corp., with additional responsibilities for Technology Assessment and Business Development. After Pfizer Inc. acquired Pharmacia, Dr. Robb held various roles within Pfizer, including Director, Senior Director of Biologicals Development, Senior Director for Market Support, Executive Director of Global Project Development & Clinical Research, and in 2007, became Senior Director and Head of Research for Embrex Inc., a wholly-owned subsidiary of Pfizer Animal Health, focusing on in ovo vaccination and poultry vaccines.

Dr. Robb earned his B.S. in Animal Science (with honors and distinction) from Cornell University in 1977 and his D.V.M. in 1981. He practiced veterinary medicine in northern New York before completing an M.S. in epidemiology at the University of Pennsylvania. He completed a residency in Veterinary Nutrition and is Board Certified in Veterinary Clinical Nutrition.

bottom of page